Insider · CIK 0001693805
Maiken Keson-Brookes
Files at MURA (Mural Oncology plc). First filing Dec 26, 2024, latest Jul 23, 2025.
In brief
Maiken Keson-Brookes files SEC Form 4 as officer at MURA (Mural Oncology plc). Since Dec 26, 2024, Maiken Keson-Brookes has reported 0 open-market buys worth $0 and 4 open-market sells worth $29k, the latest filed on Jul 23, 2025.
A track record needs three past buys with six months of prices behind them; Maiken Keson-Brookes has 0, so none is measured yet.
The newest scored trade: sold $6,379 of MURA on Jul 22, 2025, filed Jul 23, 2025, scored 0 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Mural Oncology plc | $6,379 2,572 shares | -4% | - | |
| 3Weak | Mural Oncology plc | $5,352 2,158 shares | -3% | - | |
| 3Weak | Mural Oncology plc | $9,308 2,731 shares | -4% | - | |
| 3Weak | Mural Oncology plc | $8,355 2,555 shares | -6% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 22, 2025 | MURA Mural Oncology plc | 2,572 0.01% of outstanding | $6,404 | Jul 22, 2025 | none |
| Mar 5, 2025 | MURA Mural Oncology plc | 1,469 0.01% of outstanding | $5,039 | Mar 5, 2025 | $8,347 |
| Dec 23, 2024 | MURA Mural Oncology plc | 2,555 0.01% of outstanding | $8,304 | Dec 23, 2024 | none |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | MURA Mural Oncology plc | DDisposition to issuer Ordinary Shares | -68,834 | - | - | 0 | Dec 5, 2025 |
| Dec 5, 2025 | MURA Mural Oncology plc | DDisposition to issuer Stock Option (right to buy)derivative | -54,242 | - | - | 0 | Dec 5, 2025 |
| Dec 5, 2025 | MURA Mural Oncology plc | DDisposition to issuer Stock Option (right to buy)derivative | -31,200 | - | - | 0 | Dec 5, 2025 |
| Dec 5, 2025 | MURA Mural Oncology plc | DDisposition to issuer Stock Option (right to buy)derivative | -65,000 | - | - | 0 | Dec 5, 2025 |
| Jul 22, 2025 | MURA Mural Oncology plc | SOpen-market sale Ordinary Shares10b5-1 | -2,572 | $2.48 | $6,379 | 68,834 | Jul 23, 2025 |
| Jul 18, 2025 | MURA Mural Oncology plc | SOpen-market sale Ordinary Shares10b5-1 | -2,158 | $2.48 | $5,352 | 71,406 | Jul 22, 2025 |
| Mar 3, 2025 | MURA Mural Oncology plc | AGrant or award Ordinary Shares10b5-1 | +35,000 | $0.00 | $0 | 76,295 | Mar 5, 2025 |
| Mar 4, 2025 | MURA Mural Oncology plc | SOpen-market sale Ordinary Shares10b5-1 | -1,262 | $3.36 | $4,240 | 75,033 | Mar 5, 2025 |
| Mar 5, 2025 | MURA Mural Oncology plc | SOpen-market sale Ordinary Shares10b5-1 | -1,469 | $3.45 | $5,068 | 73,564 | Mar 5, 2025 |
| Mar 3, 2025 | MURA Mural Oncology plc | AGrant or award Stock Option (right to buy)derivative10b5-1 | +65,000 | $0.00 | $0 | 65,000 | Mar 5, 2025 |
| Dec 23, 2024 | MURA Mural Oncology plc | SOpen-market sale Ordinary Shares10b5-1 | -2,555 | $3.27 | $8,355 | 41,295 | Dec 26, 2024 |
| Mar 1, 2024 | MURA Mural Oncology plc | AGrant or award Ordinary Shares | +16,800 | $0.00 | $0 | 46,007 | Mar 4, 2024 |
| Mar 1, 2024 | MURA Mural Oncology plc | AGrant or award Stock Option (right to buy)derivative | +31,200 | $0.00 | $0 | 31,200 | Mar 4, 2024 |
| Dec 14, 2023 | MURA Mural Oncology plc | AGrant or award Ordinary Shares | +29,207 | $0.00 | $0 | 29,207 | Dec 18, 2023 |
| Dec 14, 2023 | MURA Mural Oncology plc | AGrant or award Stock Option (right to buy)derivative | +54,242 | $0.00 | $0 | 54,242 | Dec 18, 2023 |
Questions about Maiken Keson-Brookes
Answered from the filings on this page, as of the latest one.
Is Maiken Keson-Brookes buying or selling?
Not in the last 12 months. Maiken Keson-Brookes's latest open-market trade on SEC Form 4 was sold $6,379 of MURA on Jul 22, 2025.
How did Maiken Keson-Brookes's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Maiken Keson-Brookes has 0.
Where does Maiken Keson-Brookes file Form 4?
Maiken Keson-Brookes has filed Form 4 at MURA (Mural Oncology plc) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.